Lefamulin targets ILF3 to overcome targeted therapy resistance in hepatocellular carcinoma []
Ontology highlight
ABSTRACT: Lefamulin targets ILF3 to overcome targeted therapy resistance in hepatocellular carcinoma []
PROVIDER: PRJNA1063443 | ENA |
REPOSITORIES: ENA
ACCESS DATA